Phage Prevalence in the Human Urinary Tract-Current Knowledge and Therapeutic Implications

Maciej Żaczek1, Beata Weber-Dąbrowska1,2, Ryszard Międzybrodzki1,2,3

  • 1Bacteriophage Laboratory, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.

Microorganisms
|November 20, 2020
PubMed

Insights

Phages, viruses that infect bacteria, are abundant in the human body, including the urinary tract. Their role in urinary tract infections (UTIs) and potential therapeutic uses are under investigation.

Area of Science:

  • Microbiology
  • Virology
  • Human Microbiome Research

Background:

  • Metagenomic analyses reveal a high abundance of bacteriophages (phages) in various human body sites, often exceeding eukaryotic virus numbers.
  • Phages are known to influence bacterial metabolism and community structure, but their specific roles in human body fluids remain largely unexplored.
  • The human urobiome, particularly phage presence and function in the urinary tract, is under-investigated.

Purpose of the Study:

  • To review current data on phage presence within the human urinary tract.
  • To explore the potential implications of phage presence in urinary tract health and disease.
  • To discuss the therapeutic potential of phages in managing urinary tract infections (UTIs).

Main Methods:

  • Literature review of recent metagenomic studies and scientific reports.
  • Analysis of data concerning phage distribution across different human anatomical sites.
  • Synthesis of information on the known functions of phages in microbial ecosystems.

Main Results:

  • Phages are demonstrably abundant in the human body, including urine samples.
  • The presence and activity of phages in the urinary tract are linked to individual health status.
  • Limited data exists on the specific role of phages in the context of urinary tract infections.

Conclusions:

  • Phages are a significant component of the human microbiome, including the urobiome.
  • Further research is needed to elucidate the precise role of phages in urinary tract health and disease.
  • Phage therapy presents a potential avenue for novel treatments for recurrent urinary tract infections.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
75.4K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
139
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
344
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
66.1K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
913
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
702